Article
High-resolution detection of RPS24 microexon variations reveals novel splicing patterns in response to KRAS-targeted therapy in lung adenocarcinoma.
BMB reports - 1 Jun 2025
Nam Dahye, Tian Bin, Park Jiyeon, Chung Yeun-Jun
Abstract excerpt
Alternative splicing (AS) dysregulation is increasingly recognized as a critical factor in cancer progression and drug response. However, precisely detecting and characterizing complex splicing events, particularly those involving microexons, remains technically challenging. Ribosomal Protein 24 (RPS24), which contains three microexons (3, 18, and 22 bp), serves as an ideal model for studying complex AS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
